To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Clinical trial NCT03159585 · COMPLETED

Trial details

NCT number: NCT03159585
Sponsor: Zhujiang Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Cancer Stage IV Gastric Cancer Stage IV Esophageal Cancer, Stage IV Bone and Soft Tissue Tumors Breast Cancer Stage IV Bladder Carcinoma Stage IV Prostate Carcinoma Stage IV Thyroid Cancer Stage IV Ovarian Cancer Stage IV Solid Tumor

Start date: 2017-04-14
Primary completion: 2019-06-04
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.